The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial
- PMID: 30408160
- DOI: 10.1111/bjh.15629
The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial
Keywords: chronic myeloid leukaemia; imatinib; lymphocyte subsets; treatment discontinuation; tyrosine kinase inhibitors.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical